Recently, we reported that the FDA-approved drug disulfiram when combined with copper (DSF-Cu) enhances uptake in cancer cells and inhibits pNFκB leading to decreased XIAP, enhanced oxidative stress-induced apoptosis and significant inhibition of SUM149 tumor growth in a murine xenograft model [19]. The gene discussed is XIAP; the disease is neoplasm.